Furosemide Therapy in Congestive Heart Failure Management

Introduction to Furosemide Therapy

The American Heart Association recommends furosemide as the cornerstone diuretic for CHF, to be prescribed to all patients with current or prior evidence of fluid retention, combined with an ACE inhibitor, beta-blocker, and aldosterone antagonist 1
The American College of Cardiology states that diuretics are the only drugs that can adequately control fluid retention in heart failure, and ACE inhibitors and digitalis cannot substitute for diuretics in managing volume overload 1, 2

Loop diuretics like furosemide are preferred over thiazides because they increase sodium excretion up to 20-25% of the filtered load, maintain efficacy even with impaired renal function, and enhance free water clearance, according to the American College of Cardiology 2
The European Society of Cardiology notes that furosemide is FDA-approved for treating edema associated with congestive heart failure and is particularly useful when greater diuretic potential is desired 3

The American Heart Association recommends starting with furosemide 20-40 mg once or twice daily, and increasing the dose until urine output increases and weight decreases by 0.5-1.0 kg daily 1, 3
The European Society of Cardiology suggests that further increases in dose or frequency (twice-daily dosing) may be required to maintain active diuresis, with a maximum daily dose of 600 mg 1, 3

The American College of Cardiology recommends having patients record daily weights and adjust diuretic dose if weight increases or decreases beyond a specified range, to maintain treatment and prevent recurrence of volume overload 1, 4
The European Society of Cardiology advises aiming for the lowest dose that maintains dry weight, with frequent adjustments as needed 3, 5

The American College of Cardiology states that diuretics should never be used alone in Stage C heart failure, and must be combined with ACE inhibitors or ARBs, beta-blockers, and aldosterone antagonists 2, 4

The American Heart Association recommends considering adding a thiazide-type diuretic or spironolactone if adequate diuresis is not achieved with loop diuretics alone, with careful monitoring for hypokalemia, renal dysfunction, and hypovolemia 1, 3, 5

The American College of Cardiology advises holding diuretics until adequate perfusion is restored in patients with SBP <90 mmHg, as they can worsen hypotension and end-organ perfusion 4

The American Heart Association notes that principal adverse effects of furosemide include electrolyte depletion, hypotension, and azotemia, which can be enhanced when two diuretics are combined 1, 4

The American College of Cardiology warns that inappropriately low doses of furosemide can result in fluid retention, diminish response to ACE inhibitors, and increase risk of treatment with beta-blockers 1, 2, 4
The European Society of Cardiology advises that inappropriately high doses can lead to volume contraction, increase risk of hypotension with ACE inhibitors and vasodilators, and increase risk of renal insufficiency with ACE inhibitors and ARBs 1, 2, 4